Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$2.01 - $7.19 $205,683 - $735,752
-102,330 Closed
0 $0
Q1 2022

May 04, 2022

SELL
$6.24 - $14.04 $44,304 - $99,684
-7,100 Reduced 6.49%
102,330 $639,000
Q4 2021

Feb 07, 2022

SELL
$11.33 - $29.38 $143,324 - $371,657
-12,650 Reduced 10.36%
109,430 $1.24 Million
Q3 2021

Nov 02, 2021

BUY
$16.0 - $22.51 $1.95 Million - $2.75 Million
122,080 New
122,080 $2.3 Million

Others Institutions Holding OMGA

About Omega Therapeutics, Inc.


  • Ticker OMGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,853,400
  • Market Cap $37.8M
  • Description
  • Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...
More about OMGA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.